title: [Pharmacogenetic studies: evaluation guidelines for research ethics committees. Scientific background and legal framework (I)].
authors.affiliation: Departamento Médico, GlaxoSmithKline, Tres Cantos, Madrid, España. jrv76999@gsk.com
authors.forename: Julio
authors.initials: J
authors.lastname: Rodríguez-Villanueva
authors.forename: M Jesús
authors.initials: MJ
authors.lastname: Alsar
authors.forename: Cristina
authors.initials: C
authors.lastname: Avendaño
authors.forename: Cristina
authors.initials: C
authors.lastname: Gómez-Piqueras
authors.forename: Fernando
authors.initials: F
authors.lastname: García-Alonso
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards; D017041:Ethics Committees; D028744:Ethics Committees, Research / Q000592:standards*; D005069:Evaluation Studies as Topic; D006805:Human Experimentation / Q000592:standards*; D006801:Humans; D010597:Pharmacogenetics / Q000941:ethics* / Q000331:legislation & jurisprudence*; D017410:Practice Guidelines as Topic / Q000592:standards*